Is it odd for a silicon vendor like Intel to get into the medical device business that they have to market and service as opposed to allowing another OEM to rebrand or license Intel’s IP?
I guess I need to look into this a little more, but that’s exactly what Intel has done. The device just received FDA approval and is called the “Intel Health Guide”. It’s considered a personal health system or a care management tool for healthcare professionals who manage patients with chronic conditions.
Essentially, your doctor sends you home with this, the patient can have the device take readings from the in-home patient (like blood pressure), then uploads the results to the Dr. who has a device or software on the backend to make assessments of the patient’s state.
I can definitely see a great use for this, especially for the elderly, but I would like to know the cost and what kind of revenue stream they’ll see from it since this is a gamble on their part.